BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33001236)

  • 1. [Individualized use of levosimendan in cardiac surgery].
    Woehrle T; Mehringer L; Juchem G; Dashkevich A; Weis M; Schünemann M; Kilger E
    Anaesthesist; 2021 Mar; 70(3):204-212. PubMed ID: 33001236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
    Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
    JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011312. PubMed ID: 28770972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis.
    Wang B; He X; Gong Y; Cheng B
    Biomed Res Int; 2018; 2018():7563083. PubMed ID: 29854789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy.
    Jiménez-Rivera JJ; Álvarez-Castillo A; Ferrer-Rodríguez J; Iribarren-Sarrías JL; García-González MJ; Jorge-Pérez P; Lacalzada-Almeida J; Pérez-Hernández R; Montoto-López J; Martínez-Sanz R
    J Cardiothorac Surg; 2020 May; 15(1):108. PubMed ID: 32448319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
    Santillo E; Migale M; Massini C; Incalzi RA
    Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
    Grieshaber P; Lipp S; Arnold A; Görlach G; Wollbrück M; Roth P; Niemann B; Wilhelm J; Böning A
    J Cardiothorac Surg; 2016 Dec; 11(1):162. PubMed ID: 27906091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.
    Ricci Z; Garisto C; Favia I; Vitale V; Di Chiara L; Cogo PE
    Intensive Care Med; 2012 Jul; 38(7):1198-204. PubMed ID: 22527079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early levosimendan administration is associated with decreased mortality after cardiac surgery.
    Treskatsch S; Balzer F; Geyer T; Spies CD; Kastrup M; Grubitzsch H; Wernecke KD; Erb JM; Braun JP; Sander M
    J Crit Care; 2015 Aug; 30(4):859.e1-6. PubMed ID: 25837801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study.
    Shah B; Sharma P; Brahmbhatt A; Shah R; Rathod B; Shastri N; Patel J; Malhotra A
    Indian J Pharmacol; 2014; 46(1):29-34. PubMed ID: 24550581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study).
    Caruba T; Hourton D; Sabatier B; Rousseau D; Tibi A; Hoffart-Jourdain C; Souag A; Freitas N; Yjjou M; Almeida C; Gomes N; Aucouturier P; Djadi-Prat J; Menasché P; Chatellier G; Cholley B
    J Cardiothorac Surg; 2016 Aug; 11(1):127. PubMed ID: 27496105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan for Hemodynamic Support after Cardiac Surgery.
    Landoni G; Lomivorotov VV; Alvaro G; Lobreglio R; Pisano A; Guarracino F; Calabrò MG; Grigoryev EV; Likhvantsev VV; Salgado-Filho MF; Bianchi A; Pasyuga VV; Baiocchi M; Pappalardo F; Monaco F; Boboshko VA; Abubakirov MN; Amantea B; Lembo R; Brazzi L; Verniero L; Bertini P; Scandroglio AM; Bove T; Belletti A; Michienzi MG; Shukevich DL; Zabelina TS; Bellomo R; Zangrillo A;
    N Engl J Med; 2017 May; 376(21):2021-2031. PubMed ID: 28320259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study.
    Anastasiadis K; Antonitsis P; Vranis K; Kleontas A; Asteriou C; Grosomanidis V; Tossios P; Argiriadou H
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):740-747. PubMed ID: 27378790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.
    Amiet V; Perez MH; Longchamp D; Boulos Ksontini T; Natterer J; Plaza Wuthrich S; Cotting J; Di Bernardo S
    Pediatr Cardiol; 2018 Jan; 39(1):19-25. PubMed ID: 28884218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.